Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Eibl

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
British Journal of Haematology|August 1, 1988
Issues associated with safety testing of blood products in endemic areasJ Eibl, G Eder, K Anderle
Thrombosis and Haemostasis|November 1, 1991
Antibody to hepatitis C virus after a vapor heated factor VIII concentrate--lack of evidenceK Anderle, G Eder, J Eibl
Wiener Klinische Wochenschrift|May 5, 1999
New technologies for vaccinesF Dorner, J Eibl, P N Barrett
Developments in Biological Standardization|January 1, 1993
At what stage should virus inactivation be carried out?F Dorner, P N Barrett, J Eibl
Biologicals : Journal of the International Association of Biological Standardization|September 1, 1996
Nanofiltration of immunoglobulin with 35-nm filters fails to remove substantial amounts of HCVJ Eibl, N Barrett, T Hämmerle, et al.
Journal of AOAC International|August 15, 2001
Separation and quantitation of alkylphosphocholines and analogues of different liposome formulations by HPTLCH Ratz, H Schnell, M Rischer, et al.
Lancet (London, England)|February 19, 1994
High-purity factor concentrates in prevention of AIDSH P Schwarz, M Kunschak, W Engl, et al.
Cancer Treatment Reviews|December 1, 1987
New cytostatics with experimentally different toxic profilesM R Berger, C Muschiol, D Schmähl, et al.
Biochemistry|April 22, 1986
Spontaneous vesiculation of aqueous lipid dispersionsH Hauser, N Gains, H J Eibl, et al.
Journal of Medical Virology|May 1, 1996
Determination of the inactivation kinetics of hepatitis A virus in human plasma products using a simple TCID50 assayP N Barrett, H Meyer, I Wachtel, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
British Journal of Haematology|August 1, 1988
Issues associated with safety testing of blood products in endemic areasJ Eibl, G Eder, K Anderle
Thrombosis and Haemostasis|November 1, 1991
Antibody to hepatitis C virus after a vapor heated factor VIII concentrate--lack of evidenceK Anderle, G Eder, J Eibl
Wiener Klinische Wochenschrift|May 5, 1999
New technologies for vaccinesF Dorner, J Eibl, P N Barrett
Developments in Biological Standardization|January 1, 1993
At what stage should virus inactivation be carried out?F Dorner, P N Barrett, J Eibl
Biologicals : Journal of the International Association of Biological Standardization|September 1, 1996
Nanofiltration of immunoglobulin with 35-nm filters fails to remove substantial amounts of HCVJ Eibl, N Barrett, T Hämmerle, et al.
Journal of AOAC International|August 15, 2001
Separation and quantitation of alkylphosphocholines and analogues of different liposome formulations by HPTLCH Ratz, H Schnell, M Rischer, et al.
Lancet (London, England)|February 19, 1994
High-purity factor concentrates in prevention of AIDSH P Schwarz, M Kunschak, W Engl, et al.
Cancer Treatment Reviews|December 1, 1987
New cytostatics with experimentally different toxic profilesM R Berger, C Muschiol, D Schmähl, et al.
Biochemistry|April 22, 1986
Spontaneous vesiculation of aqueous lipid dispersionsH Hauser, N Gains, H J Eibl, et al.
Journal of Medical Virology|May 1, 1996
Determination of the inactivation kinetics of hepatitis A virus in human plasma products using a simple TCID50 assayP N Barrett, H Meyer, I Wachtel, et al.
Pageof 3